An inexpensive 20-year-old drug for an unusual medical condition may soon cost patients $80,000, due to a [ legal maneuver by drug barons ]( http://www.thestreet.com/story/12895858/1/catalyst-pharma-closer-to-unconscionable-price-hike-for-rare-disease-drug.html ) . The long-known generic drug colchicine, used for gout, was made a monopoly through a similar maneuver. The same sort of corrupt scheme for new monopolies on old drugs exists in Europe.
Ссылка: https://stallman.org/archives/2014-jul-oct.html#06_October_2014_%28Monopolies_on_old_drugs%29